Dr Fazel Shabanpoor is Fight MND Senior Research Fellow and heads the Peptide and Oligonucleotide Therapeutics Laboratory at the Florey Institute of Neuroscience and Mental Health. He obtained a Ph.D in 2010 under supervision of Prof. John Wade. He received CJ Martin Fellowship in 2011 and spent two years in the UK working on antisense drug development and blood-brain barrier-crossing peptides with Prof. Michael Gait (MRC Laboratory of Molecular Biology in Cambridge) and Prof. Mathew Wood (Dept of Physiology, Anatomy & Genetics, University of Oxford). In 2014, he returned to Australia and formed his own group at the Florey Neuroscience Institute. His research interest spans across the fields of oligonucleotides and peptides with the focus on developing these biomolecules as therapeutics for neurodegenerative diseases. In parallel to the development of ASOs, he is also developing peptide-based ASO delivery platform for systemic CNS delivery of the therapeutic ASOs.